首页> 外文OA文献 >Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis
【2h】

Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis

机译:内脏Leishmaniaisis IgG1的治愈率与复发的快速监测,以及kala-azar真皮Leishmaniaisis诊断的潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: There is a recognized need for an improved diagnostic test to assess post-chemotherapeutic treatment outcome in visceral leishmaniasis (VL) and to diagnose post kala-azar dermal leishmaniasis (PKDL). We previously demonstrated by ELISA and a prototype novel rapid diagnostic test (RDT), that high anti-Leishmania IgG1 is associated with post-treatment relapse versus cure in VL.Methodology: Here, we further evaluate this novel, low-cost RDT, named VL Sero K-SeT, and ELISA for monitoring IgG1 levels in VL patients after treatment. IgG1 levels against L. donovani lysate were determined. We applied these assays to Indian sera from cured VL at 6 months post treatment as well as to relapse and PKDL patients. Sudanese sera from pre- and post-treatment and relapse were also tested.Results: Of 104 paired Indian sera taken before and after treatment for VL, when deemed clinically cured, 81 (77.9%) were positive by VL Sero K-SeT before treatment; by 6 months, 68 of these 81 (84.0%) had a negative or reduced RDT test line intensity. ELISAs differed in positivity rate between pre- and post-treatment (p = 0.0162). Twenty eight of 33 (84.8%) Indian samples taken at diagnosis of relapse were RDT positive. A comparison of Indian VL Sero K-SeT data from patients deemed cured and relapsed confirmed that there was a significant difference (p < 0.0001) in positivity rate for the two groups using this RDT. Ten of 17 (58.8%) Sudanese sera went from positive to negative or decreased VL Sero K-SeT at the end of 11–30 days of treatment. Forty nine of 63 (77.8%) PKDL samples from India were positive by VL Sero K-SeT.Conclusion: We have further shown the relevance of IgG1 in determining clinical status in VL patients. A positive VL Sero K-SeT may also be helpful in supporting diagnosis of PKDL. With further refinement, such as the use of specific antigens, the VL Sero K-SeT and/or IgG1 ELISA may be adjuncts to current VL control programmes.
机译:背景:有一个认识到需要一种改进的诊断测试,以评估在内脏利什曼病(VL)后化疗治疗结果和诊断后黑热病皮肤利什曼病(PKDL)。我们以前用ELISA和原型新颖的快速诊断测试(RDT)证明,高抗利什曼原虫的IgG1与治疗后复发与在VL.Methodology治疗有关:在这里,我们进一步评估这种新型的,低成本的RDT,命名VL血清K-SET和ELISA监测IgG1的水平VL患者治疗后。对杜氏利什曼原虫裂解IgG1的水平确定。我们应用这些试验从治愈VL印度血清在6个月后的治疗以及复发和PKDL患者。从预处理和后处理和复发苏丹血清也tested.Results:104配对印度血清由VL血清K-组治疗前治疗前和治疗为VL,当视为临床治愈,81(77.9%)后取出进行正面;通过6个月,这些81(84.0%)68有一个负的或降低的RDT测试线强度。不同的ELISA中阳性率预处理和后处理(p值= 0.0162)之间。二十八个在复发诊断采取33(84.8%)的中国样品RDT阳性。从印度患者血清VL K-组数据的比较视为固化和复发性确认,在阳性率使用此RDT两组一个显著差异(p <0.0001)。 17(58.8%)苏丹血清十从正变为负或在治疗的11-30天结束下降VL血清K-SET。四十九的63(77.8%)来自印度PKDL样品阳性血清VL K-SeT.Conclusion:我们还表明在确定VL患者的临床状态IgG1的相关性。阳性血清VL K-SET也可以是在支撑PKDL的诊断。随着进一步的改进方案中,如使用特异性抗原,所述VL SERO K-SET和/或IgG1的ELISA可以是辅助电流VL控制程序。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号